Correction: In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity
Saved in:
Format: | article |
---|---|
Language: | EN |
Published: |
BMJ Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b70a7ff9ff084f94b925b3ac4b29ca26 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity
by: Marie-Claude Bourgeois-Daigneault, et al.
Published: (2021) -
Experimental evolution of an oncolytic vesicular stomatitis virus with increased selectivity for p53-deficient cells.
by: Raquel Garijo, et al.
Published: (2014) -
Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis
by: Amanda W. K. AuYeung, et al.
Published: (2021) -
Structure of the vesicular stomatitis virus N⁰-P complex.
by: Cédric Leyrat, et al.
Published: (2011) -
Phase Transitions Drive the Formation of Vesicular Stomatitis Virus Replication Compartments
by: Bianca S. Heinrich, et al.
Published: (2018)